No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AMWL240816P1000
- 0.70
- 0.000.00%
15min DelayClose Jul 10 12:24 ET
0.00High0.00Low
0.00Open0.70Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover1189.20%IV96.55%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type-0.0121Delta0.0012Gamma12.43Leverage Ratio-0.0174Theta-0.0004Rho-0.15Eff Leverage0.0007Vega
Intraday
- 5D
- Daily
News
Amwell to Report Second Quarter 2024 Operating Results
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell (NYSE:AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the
Express News | American Well- on July 10, Effected Reverse Stock Split of Class a Common Stock, Class B Common Stock & Class C Common Stock at Ratio of 1-for-20
Italy Telehealth Market Outlook to 2033, Featuring Teladoc Health and American Well Corporation
Morgan Stanley Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $20
Morgan Stanley analyst Craig Hettenbach maintains $American Well(AMWL.US)$ with a hold rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 59.2%
Analysts' Top Healthcare Picks: Astellas Pharma (ALPMF), American Well (AMWL)
Morgan Stanley Sticks to Their Hold Rating for American Well (AMWL)
Comments
Investors' belief in the company's poor revenue performance and lower-than-average forecasted growth may be causing the low P/S ratio. A change of fortune is needed to justify a higher P/S in the future.
The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
![]()
$Teladoc Health(TDOC.US$
A...
A...
+2
7
Insiders selling activity and absence of recent purchases hint at potential weakness in American Well's stock. Yet, notable insider ownership implies alignment with smaller investors. Caution advised for potential risks.
$American Well(AMWL.US$ nice inflow
Read more